鼓室应用地塞米松或甲泼尼龙治疗突发性聋疗效比较的Meta分析
程雨芳;刘爱国;刘磊;
1:华中科技大学同济医学院附属同济医院耳鼻咽喉-头颈外科
2:武汉科技大学附属天佑医院





1 中华耳鼻咽喉头颈外科杂志编辑委员会,中华医学会耳鼻咽喉头颈外科学分会.突发性聋的诊断和治疗指南(2005年,济南)[J].中华耳鼻咽喉头颈外科杂志,2006,41:569.
2 潘树义,杨晨,赵津京.突发性耳聋发病机制的研究进展[J].中华临床医师杂志(电子版),2013,7:337.
3 Wilson WR,Veltri RW,Laird N,et al.Viral and epidemiologic studies of idiopathic sudden hearing loss[J].Otolaryngol Head Neck Surg,1983,91:653.
4 Shirwany NA,Seidman MD,Tang W.Effect of transtympanic injection of steroids on cochlear blood flow,auditory sensitivity,and histology in the guinea pig[J].Am J Otol,1998,19:230.
5 李新华.地塞米松与甲泼尼龙治疗突发性耳聋的疗效比较[J].中国医药指南,2017,15:154.
6 李晖,刘莉,李俊.两种糖皮质激素鼓室注射治疗突发性聋的疗效比较[J].听力学及言语疾病杂志,2014,22:417.
7 卫平存,胡金旺.甲强龙、地塞米松治疗突发性耳聋的应用比较[J].辽宁医学杂志,2014,28:4.
8 杨军,黄莉,施俊,等.鼓室内注射地塞米松或甲泼尼龙治疗突发性聋的疗效观察[J].临床耳鼻咽喉头颈外科杂志,2010,24:594.
9 Berjis N,Soheilipour S,Musavi A,et al.Intratympanic dexamethasone injection vs methylprednisolone for the treatment of refractory sudden sensorineural hearing loss[J].Adv Biomed Res,2016,5:111.
10 刘栖如,刘海兵.鼓室内注射甲基泼尼松龙与地塞米松治疗难治性突发性耳聋疗效比较[J].临床合理用药杂志,2017,10:22.
11 Kim DK.Nanomedicine for inner ear diseases:a review of recent in vivo studies[J].Biomed Res Int,2017,2017:3098230.
12 杨军,吴皓.鼓室内给药治疗内耳疾病的基础与临床[J].中华耳鼻咽喉科杂志,2004,39:770.
13 Yang J,Wu H,Zhang P,et al.The pharmacokinetic profiles of dexamethasone and methylprednisolone concentration in perilymph and plasma following systemic and local administration[J].Acta Otolaryngol,2008,128:496.
14 Parnes LS,Sun AH,Freeman DJ.Corticosteroid pharmacokinetics in the inner ear fluids:an animal study followed by clinical application[J].Laryngoscope,1999,109:1.
15 Hargunani CA,Kempton JB,DeGagne JM,et al.Intratympanic injection of dexamethasone:time course of inner ear distribution and conversion to its active form[J].Otol Neurotol,2006,27:564.
16 Haynes DS,O'Malley M,Cohen S,et al.Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy[J].Laryngoscope,2007,117:3.